2001
Self-reported zidovudine adherence among pregnant women with human immunodeficiency virus infection in four US states
Wilson T, Ickovics J, Fernandez M, Koenig L, Walter E, Project F. Self-reported zidovudine adherence among pregnant women with human immunodeficiency virus infection in four US states. American Journal Of Obstetrics And Gynecology 2001, 184: 1235-1240. PMID: 11349194, DOI: 10.1067/mob.2001.114032.Peer-Reviewed Original ResearchConceptsPregnant womenHuman immunodeficiency virus-infected pregnant womenHuman immunodeficiency virus (HIV) infectionPrenatal illicit drug useImmunodeficiency virus infectionPrenatal care settingsIllicit drug useIllicit drug usersPrenatal zidovudineZidovudine dosesZidovudine useZidovudine therapyWeeks' gestationPrenatal vitaminsIncomplete adherencePrenatal clinicsRegimen adherenceVirus infectionCare settingsPsychosocial factorsDrug usersDrug useMultivariate analysisWomenAdherenceMeasuring Adherence Among HIV-Infected Persons: Is MEMS Consummate Technology?
Samet J, Sullivan L, Traphagen E, Ickovics J. Measuring Adherence Among HIV-Infected Persons: Is MEMS Consummate Technology? AIDS And Behavior 2001, 5: 21-30. DOI: 10.1023/a:1009503320498.Peer-Reviewed Original ResearchMedication Event Monitoring SystemMeasurement of adherencePatient lifestyle factorsEvent Monitoring SystemClinical research settingAntiretroviral medicationsHIV medicationsMedication adherenceAdherence aidsLifestyle factorsHIV epidemicAdherence informationCritical research prioritiesHIV researchMedicationsAdherenceHIVPill boxesResearch settingsResearch prioritiesResearch studiesRegimenPatientsUnique challenges
2000
Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: The AACTG Adherence Instruments
Chesney M, Ickovics J, Chambers D, Gifford A, Neidig J, Zwickl B, Wu A, GROUP P. Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: The AACTG Adherence Instruments. AIDS Care 2000, 12: 255-266. PMID: 10928201, DOI: 10.1080/09540120050042891.Peer-Reviewed Original ResearchConceptsAdult AIDS Clinical Trials GroupCent of patientsClinical trialsAntiretroviral therapyAdherence instrumentAIDS Clinical Trials GroupCombination antiretroviral therapyClinical Trials GroupSelf-reported adherenceHIV clinical trialsAdherent patientsAntiretroviral medicationsTrial groupLow adherenceSelf-report questionnairesCommon reasonPatientsDrug resistanceTrialsImproved healthMedicationsProtease inhibitorsQuestionnaireDoseAdherence
1999
Adherence: a necessity for successful HIV combination therapy.
Chesney M, Ickovics J, Hecht F, Sikipa G, Rabkin J. Adherence: a necessity for successful HIV combination therapy. AIDS 1999, 13 Suppl A: s271-8. PMID: 10885784.Peer-Reviewed Original ResearchConceptsCombination therapyHIV/AIDSHIV combination therapySuccessful treatment outcomeEmergence of resistancePatient adherenceClinical trialsDisease progressionLong-term benefitsRisk factorsHIV therapyTreatment outcomesTherapyAdherence researchResistant strainsHealth benefitsAdherenceIntervention programsVirus breakthroughAIDSIntervention effortsDifferent populationsValid methodFocused effortsHIV
1997
Issues Regarding Antiretroviral Treatment for Patients With HIV-1 Infection
Ickovics J, Chesney M. Issues Regarding Antiretroviral Treatment for Patients With HIV-1 Infection. JAMA 1997, 278: 1233-1234. PMID: 9333258, DOI: 10.1001/jama.1997.03550150037025.Peer-Reviewed Original ResearchConceptsAdherence behaviorPlasma human immunodeficiency virus (HIV) RNA levelsHuman immunodeficiency virus (HIV) RNA levelsDrug resistanceVirus RNA levelsHIV-1 infectionDrug regimenHIV diseaseAntiretroviral treatmentViral loadTreatment regimensCombination therapyPatients' willingnessDisease progressionCostly regimensConsensus statementMore pillsPatient healthRegimensRNA levelsAdherenceDearth of informationTherapyBrief periodNonadherence